Valuation: Cellnovo

Market Cap 2.44M 2.17M 2.01M 1.83M 3.43M 231M 3.49M 24.12M 9.49M 121M 9.14M 8.95M 386M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 11.1M 10.29M 9.35M 17.55M 1.18B 17.84M 123M 48.52M 617M 46.74M 45.76M 1.97B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+0.90%-1.34%+3.31%+61.14% 3,928B
+4.42%-7.00%+7.04%+1,039.33% 447B
+1.22%-5.34%-53.08%+20.04% 389B
+1.51%-13.92%+64.12%+174.67% 280B
+0.31%+2.77%-16.24%+57.01% 259B
+0.44%-13.05%+81.63%+395.72% 233B
+1.93%+2.98%-21.26%+29.02% 147B
+1.75%-10.46%+103.58%+199.05% 124B
+0.77%+3.50%-28.23%-55.65% 95.43B
Average +1.33%-6.42%+15.65%+213.37% 590.23B
Weighted average by Cap. +1.22%-3.81%+5.98%+151.16%

Financials

2018 2019 *
Net sales 3.32M 2.96M 2.74M 2.49M 4.68M 315M 4.76M 32.9M 12.94M 165M 12.46M 12.2M 526M -
Net income -15.94M -14.21M -13.16M -11.97M -22.46M -1.51B -22.82M -158M -62.08M -790M -59.8M -58.55M -2.52B -
Net Debt 10.02M 8.93M 8.28M 7.52M 14.12M 950M 14.35M 99.26M 39.03M 497M 37.6M 36.82M 1.59B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock